Skip to main content

Cutaneous Neuroendocrine Tumors

  • Chapter
  • First Online:
Endocrine Pathology:
  • 2208 Accesses

Abstract

Merkel cell carcinomas are aggressive primary cutaneous neuroendocrine tumors that have recently been associated with Merkel cell polyomavirus. Visceral neuroendocrine tumors can involve the skin secondarily, usually in the setting of disseminated disease but can be the primary manifestation of disease. Knowledge of the clinical, histologic, and immunophenotypic features of tumors is essential for the diagnosis of neuroendocrine tumors in the skin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goessling W, McKee PH, Mayer RJ (2002) Merkel cell carcinoma. J Clin Oncol 20(2):588–598

    Article  PubMed  Google Scholar 

  2. Heath M, Jaimes N, Lemos B et al (2008) Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 58(3):375–381

    Article  PubMed  Google Scholar 

  3. Erickson LA, Papotti M, Volante M, Jin L, Lewis JE, Lloyd RV (2003) Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers. Endocr Pathol 14(3):221–229

    Article  CAS  PubMed  Google Scholar 

  4. Eusebi V, Capella C, Cossu A, Rosai J (1992) Neuroendocrine carcinoma within lymph nodes in the absence of a primary tumor, with special reference to Merkel cell carcinoma. Am J Surg Pathol 16(7):658–666

    Article  CAS  PubMed  Google Scholar 

  5. Inoue T, Yoneda K, Manabe M, Demitsu T (2000) Spontaneous regression of merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group. J Dermatol Sci 24(3):203–211

    Article  CAS  PubMed  Google Scholar 

  6. Hodgson NC (2005) Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89(1):1–4

    Article  PubMed  Google Scholar 

  7. Becker JC, Kauczok CS, Ugurel S, Eib S, Brocker EB, Houben R (2008) Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy. J Dtsch Dermatol Ges 6(9):709–719

    Article  PubMed  Google Scholar 

  8. Penn I, First MR (1999) Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation 68(11):1717–1721

    Article  CAS  PubMed  Google Scholar 

  9. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW (2002) Merkel cell carcinoma and HIV infection. Lancet 359(9305):497–498

    Article  PubMed  Google Scholar 

  10. Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB (2006) Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 15(8):1545–1549

    Article  PubMed  Google Scholar 

  11. Aydin A, Kocer NE, Bekerecioglu M, Sari I (2003) Cutaneous undifferentiated small (Merkel) cell carcinoma, that developed synchronously with multiple actinic keratoses, squamous cell carcinomas and basal cell carcinoma. J Dermatol 30(3):241–244

    PubMed  Google Scholar 

  12. Nagy J, Feher LZ, Sonkodi I, Lesznyak J, Ivanyi B, Puskas LG (2005) A second field metachronous Merkel cell carcinoma of the lip and the palatine tonsil confirmed by microarray-based comparative genomic hybridisation. Virchows Arch 446(3):278–286

    Article  PubMed  Google Scholar 

  13. Andea AA, Coit DG, Amin B, Busam KJ (2008) Merkel cell carcinoma: histologic features and prognosis. Cancer 113(9):2549–2558

    Article  PubMed  Google Scholar 

  14. Battifora H, Silva EG (1986) The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma. Cancer 58(5):1040–1046

    Article  CAS  PubMed  Google Scholar 

  15. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL (1997) Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21(2):226–234

    Article  CAS  PubMed  Google Scholar 

  16. Nicholson SA, McDermott MB, Swanson PE, Wick MR (2000) CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 8(1):37–41

    Article  CAS  PubMed  Google Scholar 

  17. Mhawech-Fauceglia P, Herrmann F, Bshara W et al. (2006) Friend leukemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol 60(6):694–700

    Google Scholar 

  18. Yang DT, Holden JA, Florell SR (2004) CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors. J Cutan Pathol 31(3):254–261

    Article  PubMed  Google Scholar 

  19. He H, Fang W, Liu X, Weiss LM, Chu PG (2009) Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases. Appl Immunohistochem Mol Morphol 17(1):40–46

    Article  CAS  PubMed  Google Scholar 

  20. Carvalho J, Fullen D, Lowe L, Su L, Ma L (2009) Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma. J Cutan Pathol 36(2):206–210

    Article  PubMed  Google Scholar 

  21. Buresh CJ, Oliai BR, Miller RT (2008) Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol 129(6):894–898

    Article  PubMed  Google Scholar 

  22. Joachims Z, Feinmesser R, Purim O et al (2008) Cyclooxygenase-2 expression in primary and metastatic Merkel cell carcinoma. Appl Immunohistochem Mol Morphol 16(5):442–446

    Article  CAS  PubMed  Google Scholar 

  23. Sadow PM, Rumilla KM, Erickson LA, Lloyd RV (2008) Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr Pathol 19(2):97–103

    Article  CAS  PubMed  Google Scholar 

  24. Asioli S, Righi A, Volante M, Eusebi V, Bussolati G (2007) p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 110(3):640–647

    Article  PubMed  Google Scholar 

  25. Kim J, McNiff JM (2008) Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma. Mod Pathol 21(6):764–769

    Article  CAS  PubMed  Google Scholar 

  26. Fernandez-Figueras MT, Puig L, Musulen E et al (2007) Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol 20(1):90–101

    Article  CAS  PubMed  Google Scholar 

  27. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319(5866):1096–1100

    Article  CAS  PubMed  Google Scholar 

  28. Feng H, Taylor JL, Benos PV et al (2007) Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol 81(20):11332–11340

    Article  CAS  PubMed  Google Scholar 

  29. Kassem A, Schopflin A, Diaz C et al (2008) Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 68(13):5009–5013

    Article  CAS  PubMed  Google Scholar 

  30. Larramendy ML, Koljonen V, Bohling T, Tukiainen E, Knuutila S (2004) Recurrent DNA copy number changes revealed by comparative genomic hybridization in primary Merkel cell carcinomas. Mod Pathol 17(5):561–567

    Article  CAS  PubMed  Google Scholar 

  31. Van Gele M, Leonard JH, Van Roy N et al (2002) Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer 101(2):137–145

    Article  PubMed  Google Scholar 

  32. Vasuri F, Magrini E, Foschini MP, Eusebi V (2008) Trisomy of chromosome 6 in Merkel cell carcinoma within lymph nodes. Virchows Arch 452(5):559–563

    Article  PubMed  Google Scholar 

  33. Leonard JH, Leonard P, Kearsley JH (1993) Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 67(1):65–70

    Article  CAS  PubMed  Google Scholar 

  34. Gibas Z, Weil S, Chen ST, McCue PA (1994) Deletion of chromosome arm 1p in a Merkel cell carcinoma (MCC). Genes Chromosomes Cancer 9(3):216–220

    Article  CAS  PubMed  Google Scholar 

  35. Leonard JH, Cook AL, Nancarrow D et al (2000) Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma. Cancer Detect Prev 24(6):620–627

    CAS  PubMed  Google Scholar 

  36. Popp S, Waltering S, Herbst C, Moll I, Boukamp P (2002) UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 99(3):352–360

    Article  CAS  PubMed  Google Scholar 

  37. Van Gele M, Kaghad M, Leonard JH et al (2000) Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 82(4):823–826

    Article  PubMed  Google Scholar 

  38. Kytola S, Nord B, Elder EE et al (2002) Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Genes Chromosomes Cancer 34(3):325–332

    Article  PubMed  Google Scholar 

  39. Worda M, Sreevidya CS, Ananthaswamy HN, Cerroni L, Kerl H, Wolf P (2005) T1796A BRAF mutation is absent in Merkel cell carcinoma. Br J Dermatol 153(1):229–232

    Article  CAS  PubMed  Google Scholar 

  40. Van Gele M, Leonard JH, Van Roy N, Cook AL, De Paepe A, Speleman F (2001) Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. Int J Cancer 92(3):409–413

    Article  PubMed  Google Scholar 

  41. Kartha RV, Sundram UN (2008) Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis. Mod Pathol 21(2):96–104

    CAS  PubMed  Google Scholar 

  42. Agoff SN, Lamps LW, Philip AT et al (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13(3):238–242

    Article  CAS  PubMed  Google Scholar 

  43. Ratner D, Nelson BR, Brown MD, Johnson TM (1993) Merkel cell carcinoma. J Am Acad Dermatol 29(2 Pt 1):143–156

    Article  CAS  PubMed  Google Scholar 

  44. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK (1991) Merkel cell carcinoma. Prognosis and management. Arch Surg 126(12):1514–1519

    CAS  PubMed  Google Scholar 

  45. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG (2005) Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 23(10):2300–2309

    Article  PubMed  Google Scholar 

  46. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P (2006) Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142(6):685–690

    Article  PubMed  Google Scholar 

  47. Foschini MP, Eusebi V (2000) Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 17(2):162–168

    CAS  PubMed  Google Scholar 

  48. Kasami M, Muramatsu K, Kawahata K, Yoshikawa S, Kiyohara Y (2007) Large-cell neuroendocrine carcinoma of the skin, with lymphoid stroma. Am J Dermatopathol 29(6):578–580

    Article  PubMed  Google Scholar 

  49. Spencer PS, Helm TN (1987) Skin metastases in cancer patients. Cutis 39(2):119–121

    CAS  PubMed  Google Scholar 

  50. Lookingbill DP, Spangler N, Helm KF (1993) Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 29(2 Pt 1):228–236

    Article  CAS  PubMed  Google Scholar 

  51. Lookingbill DP, Spangler N, Sexton FM (1990) Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol 22(1):19–26

    Article  CAS  PubMed  Google Scholar 

  52. Santarpia L, El-Naggar AK, Sherman SI et al (2008) Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid 18(8):901–905

    Article  CAS  PubMed  Google Scholar 

  53. Erickson LA, Lloyd RV (2004) Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol 11(4):175–189

    Article  CAS  PubMed  Google Scholar 

  54. Hirsch MS, Faquin WC, Krane JF (2004) Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid. Mod Pathol 17(6):631–636

    Article  CAS  PubMed  Google Scholar 

  55. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25(6):815–819

    Article  CAS  PubMed  Google Scholar 

  56. Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV (2004) Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol 15(3):247–252

    Article  CAS  PubMed  Google Scholar 

  57. Cai YC, Banner B, Glickman J, Odze RD (2001) Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 32(10):1087–1093

    Article  CAS  PubMed  Google Scholar 

  58. Yao GY, Zhou JL, Lai MD, Chen XQ, Chen PH (2003) Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol 9(4):858–861

    PubMed  Google Scholar 

  59. Mecca P, Busam K (2008) Primary male neuroendocrine adenocarcinoma involving the nipple simulating Merkel cell carcinoma – a diagnostic pitfall. J Cutan Pathol 35(2):207–211

    PubMed  Google Scholar 

  60. Wesche WA, Khare VK, Chesney TM, Jenkins JJ (2000) Non-hematopoietic cutaneous metastases in children and adolescents: thirty years experience at St. Jude Children’s Research Hospital. J Cutan Pathol 27(10):485–492

    Article  CAS  PubMed  Google Scholar 

  61. Duquia RP, de Almeida HL Jr, Traesel M, Jannke HA (2006) Cutaneous metastasis of pheochromocytoma in multiple endocrine neoplasia IIB. J Am Acad Dermatol 55(2):341–344

    Article  PubMed  Google Scholar 

  62. Saadat P, Cesnorek S, Ram R, Kelly L, Vadmal M (2006) Primary cutaneous paraganglioma of the scalp. J Am Acad Dermatol 54(5 Suppl):S220–S223

    Article  PubMed  Google Scholar 

  63. Deyrup AT, Althof P, Zhou M et al (2004) Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol 28(12):1579–1586

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lori A. Erickson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Erickson, L.A. (2010). Cutaneous Neuroendocrine Tumors. In: Lloyd, R. (eds) Endocrine Pathology:. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1069-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1069-1_20

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1068-4

  • Online ISBN: 978-1-4419-1069-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics